Published in J Exp Med on May 01, 1969
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med (1983) 14.08
Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Alterations of macrophage functions by mediators from lymphocytes. J Exp Med (1971) 7.95
The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med (1970) 7.13
Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun (1970) 5.96
Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production. J Exp Med (1973) 5.94
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Vaccines and cell-mediated immunity. Bacteriol Rev (1974) 5.42
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity. J Exp Med (1971) 4.94
Hemolysin supports survival but not entry of the intracellular bacterium Listeria monocytogenes. Infect Immun (1988) 4.90
The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med (1973) 4.51
Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity. J Exp Med (1978) 4.29
Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med (1994) 4.16
The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med (1971) 4.13
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol (1973) 4.12
The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med (1971) 4.00
The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84
In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun (1971) 3.81
Lymphocyte-mediated modification of blood-derived macrophage function in vitro; inhibition of growth of intracellular mycobacteria with lymphokines. Clin Exp Immunol (1971) 3.74
Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med (1971) 3.74
Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun (1988) 3.70
Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes. Clin Exp Immunol (1971) 3.69
Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun (1991) 3.59
Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo. J Exp Med (1982) 3.52
Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect Immun (1992) 3.52
Assessment in vitro of immunity against Toxoplasma gondii. J Exp Med (1975) 3.50
A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J Exp Med (1992) 3.37
Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection. J Exp Med (1982) 3.27
Mycobacterium. Bacteriol Rev (1977) 3.20
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish. Cell Host Microbe (2007) 3.09
The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci. J Exp Med (1971) 2.89
Listeria monocytogenes infection in nude mice. Infect Immun (1975) 2.82
H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers. J Exp Med (1977) 2.71
Cell-mediated immunity during syphilis. Br J Vener Dis (1978) 2.70
Trypanosoma cruzi: modification of macrophage function during infection. J Exp Med (1977) 2.69
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
Cell-mediated immunity to intestinal infection. Infect Immun (1980) 2.65
CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med (1992) 2.62
Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J Exp Med (1991) 2.55
On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci U S A (1996) 2.55
Salmonellosis in orally infected specific pathogen-free C57B1 mice. Infect Immun (1972) 2.50
The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes. J Exp Med (1969) 2.44
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med (1983) 2.33
Multiplication of Mycobacterium tuberculosis Within Normal and "Immune" Mouse Macrophages Cultivated With and Without Streptomycin. Infect Immun (1970) 2.31
Cell-mediated immunity in Legionnaires' disease. J Clin Invest (1983) 2.30
Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun (1989) 2.28
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci U S A (1997) 2.23
Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect Immun (1977) 2.14
MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J Exp Med (2003) 2.10
Cell-mediated resistance to infection with Listeria monocytogenes in nude mice. Infect Immun (1977) 2.08
Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun (1992) 2.07
The mediator of cellular immunity. VII. Localization of sensitized lymphocytes in inflammatory exudates. J Exp Med (1974) 2.05
Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection. J Exp Med (1990) 2.03
Acquired resistance to facultative intracellular bacteria: relationship between persistence, cross-reactivity at the T-cell level, and capacity to stimulate cellular immunity of different Listeria strains. Infect Immun (1984) 1.96
Levels of Listeria monocytogenes hemolysin are not directly proportional to virulence in experimental infections of mice. Infect Immun (1988) 1.95
Cell-mediated immune response in vitro. 3. The requirement for macrophages in cytotoxic reactions against cell-bound and subcellular alloantigens. J Exp Med (1972) 1.89
Immune response to Mycobacterium tuberculosis in rats. Infect Immun (1973) 1.86
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
Lymphocyte-mediated cellular immunity in histoplasmosis. Infect Immun (1971) 1.83
Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect Immun (1990) 1.80
The effect of cytotoxic agents on the passive transfer of cell-mediated immunity. J Exp Med (1969) 1.76
Effects of Dextran Sulfate 500 on Cell-Mediated Resistance to Infection with Listeria monocytogenes in Mice. Infect Immun (1974) 1.74
Activation of mouse peritoneal cells to kill Listeria monocytogenes by T-lymphocyte products. Infect Immun (1975) 1.72
Studies on the mechanism of endogenous pyrogen production. III. Human blood monocytes. J Exp Med (1974) 1.71
Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology (1976) 1.71
Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets. Infect Immun (1990) 1.69
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
Infection-immunity in tularemia: specificity of cellular immunity. Infect Immun (1972) 1.62
Function and antigen recognition pattern of L3T4+ T-cell clones from Mycobacterium tuberculosis-immune mice. Infect Immun (1986) 1.61
Suppression of cell-mediated immunity to infection by an antimitotic drug. Further evidence that migrant macrophages express immunity. J Exp Med (1970) 1.61
Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun (1993) 1.60
Cellular basis for genetically determined enhanced resistance of certain mouse strains to listeriosis. Infect Immun (1980) 1.57
Cell to cell interaction in the immune response. V. Target cells for tolerance induction. J Exp Med (1970) 1.55
The inlAB locus mediates the entry of Listeria monocytogenes into hepatocytes in vivo. J Exp Med (1996) 1.55
Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation. Infect Immun (1983) 1.53
Mediation of immunity to intracellular infection (Toxoplasma and Besnoitia) within somatic cells. Infect Immun (1978) 1.52
Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse. Immunology (1977) 1.52
Cell-mediated immunity against Besnoitia and toxoplasma in specifically and cross-immunized hamsters and in cultures. J Exp Med (1974) 1.51
Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect Immun (1998) 1.50
Induction of Resistance by Listeria monocytogenes Cell Wall Fraction. Infect Immun (1974) 1.48
The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines. J Exp Med (1973) 1.47
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Relative susceptibility of acid-fast and non-acid-fast bacteria to ultraviolet light. Appl Microbiol (1971) 1.46
Immunological control of macrophage proliferation in vivo. Infect Immun (1973) 1.46
Nonhemolytic Listeria monocytogenes mutants that are also noninvasive for mammalian cells in culture: evidence for coordinate regulation of virulence. Infect Immun (1990) 1.43
Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages. Clin Exp Immunol (1975) 1.42
Growth of typhoid and paratyphoid bacilli in intravenously infected mice. Infect Immun (1974) 1.42
Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR. Immunology (1991) 1.42
Dichotomy between macrophage activation and degree of protection against Listeria monocytogenes and Toxoplasma gondii in mice stimulated with Corynebacterium parvum. Infect Immun (1975) 1.38
In vitro guinea pig leukocyte reactions to Rickettsia rickettsii. Infect Immun (1977) 1.38
Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection. Infect Immun (1975) 1.37
Cytopathogenic effects in enterocytelike Caco-2 cells differentiate virulent from avirulent Listeria strains. J Clin Microbiol (1991) 1.37
Cellular resistance to infection. J Exp Med (1962) 30.96
THE ROUTE OF RE-CIRCULATION OF LYMPHOCYTES IN THE RAT. Proc R Soc Lond B Biol Sci (1964) 20.20
THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med (1964) 13.28
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
The host response to Calmette-Guérin bacillus infection in mice. J Exp Med (1969) 7.74
Cellular immunity. Prog Allergy (1967) 7.18
Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol (1968) 5.71
THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES. J Exp Med (1964) 5.08
Migration of lymphocytes and thymocytes in the rat. I. The route of migration from blood to spleen and lymph nodes. J Exp Med (1968) 4.55
Adoptive immunity to intracellular infection. J Immunol (1967) 4.38
The loss of macrophages from peritoneal exudates following the injection of antigens into guinea-pigs with delayed-type hypersensitivity. Immunology (1963) 4.17
Transfer of delayed-type hypersensitivity. A critical review and experimental study in the guinea pig. Prog Allergy (1967) 3.86
The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84
STONE SH: Isologous and homologous lymphoid transplants. I. The transfer of tuberculin hypersensitivity in inbred pigs. J Immunol (1961) 2.86
EFFECTS OF MITOMYCIN C ON THE CELLULAR TRANSFER OF DELAYED-TYPE HYPERSENSITIVITY IN THE GUINEA PIG. Nature (1964) 2.62
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
The regulation of pinocytosis in mouse macrophages. IV. The immunological induction of pinocytic vesicles, secondary lysosomes, and hydrolytic enzymes. J Exp Med (1967) 2.29
Cytochemical evaluation of metabolic inhibitors in cell culture. Exp Cell Res (1965) 1.80
Mechanisms of acquired resistance in mouse typhoid. J Exp Med (1966) 9.20
The host response to Calmette-Guérin bacillus infection in mice. J Exp Med (1969) 7.74
Cellular immunity. Prog Allergy (1967) 7.18
Host-parasite relations in mouse typhoid. J Exp Med (1966) 5.73
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella-infected mice. J Immunol (1968) 5.71
Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99
Infection-immunity in experimental salmonellosis. J Exp Med (1966) 4.45
The immunology of antituberculous immunity. Am Rev Respir Dis (1968) 4.17
The mediator of cellular immunity. II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med (1971) 4.13
The monocyte in cellular immunity. Semin Hematol (1970) 4.10
Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10
The relationship of delayed hypersensitivity to acquired cellular resistance. Br Med Bull (1967) 4.03
Resistance to intracellular infection. J Infect Dis (1971) 4.01
The mediator of cellular immunity. I. The life-span and circulation dynamics of the immunologically committed lymphocyte. J Exp Med (1971) 4.00
The relationship of delayed hypersensitivity to acquired antituberculous immunity. I. Tuberculin sensitivity and resistance to reinfection in BCG-vaccinated mice. Cell Immunol (1970) 3.94
The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84
The histogenesis of immunologically committed lymphocytes. Cell Immunol (1972) 3.29
Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst (1973) 3.20
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
Cell-mediated resistance to aerogenic infection of the lung. Am Rev Respir Dis (1971) 2.48
The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes. J Exp Med (1969) 2.44
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
Immune response to Mycobacterium tuberculosis in rats. Infect Immun (1973) 1.86
Properties of lymphocytes which confer adoptive immunity to tuberculosis in rats. Immunology (1973) 1.79
The effect of cytotoxic agents on the passive transfer of cell-mediated immunity. J Exp Med (1969) 1.76
The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli. Cell Immunol (1970) 1.75
The J. Burns Amberson LECTURE The induction and expression of cell-mediated hypersensitivity in the lung. Am Rev Respir Dis (1971) 1.73
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice. Infect Immun (1977) 1.67
The short lived small lymphocyte as a mediator of cellular immunity. Nature (1970) 1.51
A comparison of the Steenken minimal inhibitory concentration and the Canetti proportion methods for determining levels of drug resistance in cultures of Mycobacterium tuberculosis. Am Rev Respir Dis (1968) 1.48
Immunological control of macrophage proliferation in vivo. Infect Immun (1973) 1.46
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. J Immunol (1975) 1.37
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc. J Immunol (1975) 1.11
Peritoneal exudate T lymphocytes with specificity to sheep red blood cells. I. Production and characterization as to function and phenotype. Immunology (1979) 1.10
Site of action of serum factors that block delayed-type hypersensitivity in mice. J Exp Med (1978) 1.07
Cellular immunity. Ann Inst Pasteur (Paris) (1971) 1.06
Suppression of immunity to Mycobacterium lepraemurium infection. Infect Immun (1977) 1.04
The mediator of cellular immunity. V. Development of cellular resistance to infection in thymectomized irradiated rats. Cell Immunol (1973) 1.02
Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen. J Natl Cancer Inst (1973) 1.01
Cellular immunity and the parasite. Adv Exp Med Biol (1977) 1.01
Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. J Natl Cancer Inst (1975) 0.99
Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma. J Natl Cancer Inst (1975) 0.99
Restoration of cell-mediated immunity to animals blocked by a humoral response. J Exp Med (1974) 0.96
Delayed hypersensitivity in lung diseases. Ann N Y Acad Sci (1974) 0.90
The future of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol (1985) 0.88
The properities of lymphocytes which carry immunologic memory of phiX 174. J Immunol (1975) 0.83
Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response. J Natl Cancer Inst (1973) 0.82
The kinetics of lymphoid cell proliferation in the tuberculous mouse spleen. Cell Immunol (1972) 0.81
Mycobacterium bovis (BCG) infection of the lymph nodes of normal, immune, and cortisone-treated guinea pigs. J Natl Cancer Inst (1977) 0.80
Pillars article: the immunological basis of acquired cellular resistance. J. Exp. Med. 1964. 120: 105-120. J Immunol (2014) 0.76
Immunity to intracellular parasites--studies in vivo. Ethiop Med J (1973) 0.75
Pillars article: cellular resistance to infection. J. Exp. Med. 1962. 116: 381-406. J Immunol (2014) 0.75
T-cell-mediated immunity. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M (1975) 0.75
[Cellular immunity]. Med Lab (Stuttg) (1976) 0.75